David Lockhart, Director at Centocor

David Lockhart

Director at Centocor | Wayne, Pennsylvania, United States

Profile last verified August 2026
Pharmaceuticals Verified Profile Wayne, Pennsylvania, United States William & Mary
Verified

Work Email

***@cntus.jnj.com

Last verified September 2026

Phone Number

(215) ***-*385

United States • Phone

Free account · No credit card · 5 profiles/month

David Lockhart Socials
David Lockhart Work Experience

Product Director at Centocor/Johnson & Johnson in January 2006 - Present

Director at Centocor

Product Director at Johnson & Johnson (Centocor Ortho Biotech) in January 1999 - January 2010

David Lockhart Education

William & Mary, January 1985 to January 1989

About David Lockhart’s Current Company
Centocor

Subsidiary of Johnson & Johnson, Centocor is a biotechnology company that was founded in Philadelphia in 1979 with an initial goal of developing new diagnostic assays using monoclonal antibody technology. In 1982 Centocor developed their first product approved by the U.S. Food and Drug Administration (FDA) — a diagnostic test used to detect the rabies virus, and in that same year transitioned into a publicly traded company. Subsequently, the company moved to a larger facility in Malvern, Pennsylvania (a northwest suburb of Philadelphia). In 1984, Centocor opened an overseas plant in Leiden, the Netherlands. Eighteen years after its foundation, (in 1997), Centocor achieved its first year of operating profitability. In 1998, Centocor divested itself of its diagnostic division and launched its top-selling monoclonal antibody Remicade (infliximab) for its first FDA approved indication in Crohn's Disease. In 1999, Centocor became a wholly owned subsidiary of Johnson & Johnson, the worldwide manufacturer and marketer of healthcare products. Subsequently, Remicade's market has expanded with approvals for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, and pediatric Crohn's disease. Remicade was approved for plaque psoriasis in September 2006. Centocor also markets ReoPro (abciximab), a biologic agent indicated as an adjunct to coronary angioplasty (PTCA). Since being acquired by Johnson and Johnson, Centocor has increased its annual sales from approximately $500 million to more than $2 billion. During the same period, research and development investment increased from $75 million to more than $300 million. In 2004 Centocor purchased a new manufacturing plant in St. Louis, Missouri, and is currently opening a new manufacturing facility in County Cork, Ireland. The Dutch plant has been expanded substantially with a $250 million investment in additional production facilities, which were opened in 2006.

Discover more about Centocor
David Lockhart’s Colleagues
Elisabeth Otvospapp

Elisabeth Otvospapp

Norristown, Pennsylvania, United States

Assistant Director at Centocor

Assistant Director at Centocor R&D (Johnson & Johnson)
(January 2002 – Present)

AB

Audrey Baker

Spring House, Pennsylvania, United States

TFA (STEM teacher); (retired) RMAT, Scientific Innovation Projects_Global Regulatory Affairs (Bridges). Senior Scientist/ADTO at Janssen R&D

Scientist at Janssen R&D
(January 2002 – Present)

HX

Hongbing Xu

West Chester, Pennsylvania, United States

Senior Associate at Centocor

Scientist at Centocor
(January 2001 – Present)

BB

Bob Bischoff

Raleigh, North Carolina, United States

Sr. Executive ISG at Janssen Biotech

Sr ISG at Centocor
(Present)

CA

Chet Andruskiewicz

Newark, Delaware, United States

Experience Pharma Industry Project Manager

Dir. of Collaborations Management at Centocor, subsidiary of Johnson & Johnson
(January 2005 – Present)

AR

Alison Rogers

Wayne, Pennsylvania, United States

Associate Scientist II at Janssen R&D, Inc.

Associate Scientist II at Centocor, Johnson and Johnson
(January 2001 – Present)

Search similar profiles
Frequently asked questions about David Lockhart

What is David Lockhart email address?

Email David Lockhart at [email protected]. This email is the most updated David Lockhart's email found in 2026.

How to contact David Lockhart?

To contact David Lockhart send an email to [email protected].

What company does David Lockhart work for?

David Lockhart works for Centocor.

What is David Lockhart's role at Centocor?

David Lockhart is Director

What industry does David Lockhart work in?

David Lockhart works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free